AMED

Amedisys, Inc. (AMED)

Last Price$90.4(0.7%)
Market Cap$2,961.5M
LTM EPS
$3.9
YoY Growth
+3,810.0%
3Y CAGR
-16.6%
5Y CAGR
-0.2%
Stock quality & Intrinsic value
5/10
6.1% overvalued

Amedisys, Inc. EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
$1.2
$1.5
$1.8
$2.5
$3.3
$5.0
$4.0
($13.3)
($2.8)
($3.1)
$0.4
($0.1)
$1.1
$0.9
$3.6
$4.0
$5.6
$6.4
$3.7
($0.3)
AMED
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AMED and see if it's the right time to invest.
Dive in

Amedisys, Inc. (AMED) EPS comparison analysis

Crunching data... Almost there!

AMED key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Amedisys, Inc.'s EPS?

As of today, Amedisys, Inc.'s last 12-month EPS is $3.9, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Amedisys, Inc.'s EPS growth rate?

Over the last year, Amedisys, Inc.'s EPS growth was 3,810.0%. The average annual EPS growth rates for Amedisys, Inc. have been (14.1%) over the past three years, (0.2%) over the past five years.

3) Is Amedisys, Inc.'s EPS growth rate Good?

Over the last year, Amedisys, Inc.'s EPS growth was 3,810.0%, which is higher than industry growth of 1.0%. It indicates that Amedisys, Inc.'s EPS growth is Good.

4) How does Amedisys, Inc.'s EPS growth rate compare to its peers?

Over the last year, Amedisys, Inc.'s EPS growth was 3,810.0%, which is higher than peer median growth of 43.8%. The list of peers includes THC, HCA, CHE, UHS, DVA, ENSG, EHC, ACHC, FMS, OPCH etc.